Rigel Pharmaceuticals, Inc. (RIGL)
32.33
-0.10
(-0.31%)
USD |
NASDAQ |
Apr 20, 14:30
Rigel Pharmaceuticals SG&A Expense (Quarterly) : 29.99M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| BioMarin Pharmaceutical, Inc. | 446.21M |
| Amicus Therapeutics, Inc. | 117.08M |
| Nektar Therapeutics | 11.18M |
| Madrigal Pharmaceuticals, Inc. | 239.98M |